Henry G Lamparski

Title: **Henry G. Lamparski: Innovator in Adenoviral Vector Technologies**

Introduction

Henry G. Lamparski is a notable inventor based in San Mateo, California, recognized for his contributions to the field of biomedical innovation. With an impressive portfolio of seven patents, Lamparski has focused his research on adenoviral vectors and their applications in targeting specific cells. His innovative work has potential implications in gene therapy and cancer treatment, making him a key figure in his area of expertise.

Latest Patents

Among Lamparski's latest patents are revolutionary inventions in the realm of adenoviral vectors. One significant patent is titled "Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof." This invention highlights replication-competent adenoviral vectors designed specifically for cells that express alpha-fetoprotein (AFP). These vectors are equipped with essential adenovirus genes for replication, managed by an AFP-transcriptional regulatory element. Additionally, he has developed compositions that utilize tissue-specific adenoviral vectors, aimed at transfecting target host cells. These compositions consist of replication-competent adenovirus with a gene crucial for replication, governed by a cell type-specific transcriptional response element (TRE) and polyethylene glycol (PEG) as a masking agent.

Career Highlights

Throughout his career, Henry G. Lamparski has made substantial contributions through his work at various companies, including Calydon, Inc. and Cell Genesys, Inc. His time in these organizations has greatly influenced advancements in the field of biotechnology, particularly involving the application of adenoviral vectors in therapeutic contexts.

Collaborations

Lamparski's work in the field has also been enhanced through collaboration with notable peers, including Daniel R. Henderson and Eric R. Schuur. These partnerships have fostered innovation and have played a vital role in the development of new technologies and methods within their discipline.

Conclusion

Henry G. Lamparski stands out as a pioneering inventor whose groundbreaking work with adenoviral vectors has the potential to advance medical therapeutics significantly. With a total of seven patents, his contributions in this specialized field continue to shape the landscape of innovation in biotechnology. His career reflects not only personal achievements but also the collaborative spirit that drives forward the boundaries of scientific discovery.